387 related articles for article (PubMed ID: 10640294)
21. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
22. [Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse.
Xu JY; Tseng LF
Neuroscience; 1997 Sep; 80(2):579-85. PubMed ID: 9284359
[TBL] [Abstract][Full Text] [Related]
23. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
[TBL] [Abstract][Full Text] [Related]
24. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
[TBL] [Abstract][Full Text] [Related]
25. Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests.
Hao S; Takahata O; Iwasaki H
Life Sci; 2000 Mar; 66(15):PL195-204. PubMed ID: 11210721
[TBL] [Abstract][Full Text] [Related]
26. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
27. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
[TBL] [Abstract][Full Text] [Related]
28. Effect of diabetes on pinacidil-induced antinociception in mice.
Zushida K; Onodera K; Kamei J
Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
[TBL] [Abstract][Full Text] [Related]
29. Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
Neuroscience; 2001; 105(1):213-8. PubMed ID: 11483313
[TBL] [Abstract][Full Text] [Related]
30. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
[TBL] [Abstract][Full Text] [Related]
31. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
[TBL] [Abstract][Full Text] [Related]
32. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2.
Stone LS; Fairbanks CA; Laughlin TM; Nguyen HO; Bushy TM; Wessendorf MW; Wilcox GL
Neuroreport; 1997 Sep; 8(14):3131-5. PubMed ID: 9331928
[TBL] [Abstract][Full Text] [Related]
33. Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.
Terashvili M; Wu HE; Leitermann RJ; Sun HS; Clithero AD; Tseng LF
J Pharmacol Exp Ther; 2005 Mar; 312(3):1257-65. PubMed ID: 15542622
[TBL] [Abstract][Full Text] [Related]
34. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
Mizoguchi H; Nakayama D; Watanabe H; Ito K; Sakurada W; Sawai T; Fujimura T; Sato T; Sakurada T; Sakurada S
Eur J Pharmacol; 2006 Jul; 540(1-3):67-72. PubMed ID: 16730704
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
Bilsky EJ; Qian X; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
[TBL] [Abstract][Full Text] [Related]
36. Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone.
Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Sato T; Zadina JE; Kastin AJ; Sakurada T
Peptides; 2002 May; 23(5):895-901. PubMed ID: 12084520
[TBL] [Abstract][Full Text] [Related]
37. Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster mice.
Rady JJ; Baemmert D; Takemori AE; Portoghese PS; Fujimoto JM
Pharmacol Biochem Behav; 1997 Feb; 56(2):243-9. PubMed ID: 9050081
[TBL] [Abstract][Full Text] [Related]
38. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance.
Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R
Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017
[TBL] [Abstract][Full Text] [Related]
40. Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse.
Wu HE; MacDougall RS; Clithero AD; Leitermann RJ; Terashvili M; Tseng LF
Neurosci Lett; 2004 Jul; 365(3):157-61. PubMed ID: 15246539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
